Penumbra Inc.

PEN ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $1.40B $1.19B $1.06B $847.1M $747.6M $560.4M $547.4M $444.9M
Cost of Revenue $461.2M $439.6M $375.9M $311.9M $272.2M $222.2M $175.4M $152.4M
Gross Profit $942.4M $755.0M $682.6M $535.2M $475.4M $338.2M $372.0M $292.5M
Gross Margin 67.1% 63.2% 64.5% 63.2% 63.6% 60.3% 68.0% 65.7%
Operating Expenses
Research & Development $36.2M
SG&A Expense $663.4M $574.0M $506.5M $449.7M $378.3M $287.1M $272.7M $226.4M
Operating Income $189.2M $9.3M $73.6M $6.1M $-7.5M $-38.9M $47.5M $-852.0K
Operating Margin 13.5% 0.8% 6.9% 0.7% -1.0% -6.9% 8.7% -0.2%
Interest Expense $1.7M $1.7M $1.9M
Pretax Income $205.1M $20.9M $79.7M $3.9M $-10.5M $-38.0M $50.1M $1.6M
Income Tax Expense $27.4M $6.9M $-11.3M $5.9M $-13.1M $-18.8M $3.1M $-4.4M
Net Income $177.7M $14.0M $91.0M $-2.0M $5.3M $-15.7M $48.5M $6.6M
Net Margin 12.7% 1.2% 8.6% -0.2% 0.7% -2.8% 8.9% 1.5%
EPS (Basic) $4.57 $0.36 $2.37 $-0.05 $0.14 $-0.44 $1.39 $0.19
EPS (Diluted) $4.52 $0.36 $2.32 $-0.05 $0.14 $-0.44 $1.34 $0.18
Shares Outstanding (Basic) 38.9M 38.6M 38.4M 37.8M 36.8M 35.8M 34.8M 34.1M
Shares Outstanding (Diluted) 39.3M 39.3M 39.2M 37.8M 37.9M 35.8M 36.3M 36.1M
Dividends Per Share
← Newer Page 1 of 2 Older →